|
FTC: Patent Deals Need Not Involve Overt Payments to Be Anticompetitive
Patent settlements that involve a branded company’s commitment to not launch an authorized generic (AG) in competition with a generic company (no-AG agreements) are “without a doubt” anticompetitive pay-for-delay deals even though no cash payments are involved, the FTC says in an amicus brief.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives